Rohto Pharmaceutical. (4527.TSE) Q2 2025 Earnings

May 13Confirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
21
31
41
51

Details

Expected EPS
25
Actual EPS
27
Surprise EPS
2
Surprise Percent
+9.7%

Description

⁨Rohto Pharmaceutical.⁩ (⁦4527.TSE⁩) has reported earnings of ⁦27⁩ per share for ⁦Q2 2025⁩.

0 Comments

Share your thoughts